ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Financials / CORZ / earnings
ENVA (61) NNI (53) DAVE (76) SEZL (79) ⌘ Pro Terminal →

Core Scientific Inc. (CORZ) Next Earnings Date & Expected ±12.5% Move

$12.51 -5.62% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $12.36

Core Scientific Inc. (CORZ) carries a Roarable Rating of E (Strong Sell) with 25/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $4.26B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CORZ Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CORZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Core Scientific Inc. (NASDAQ: CORZ) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $12.51 (-5.62% 1D, market cap $4.26B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 3/20, and Executive Insider Alignment 5/20. Across 1097 tracked Financials issuers, CORZ ranks #1058 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CORZ compare to ENVA and NNI in the Financials sector?
▼

Within the Financials sector (Finance: Consumer Services), CORZ carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, ENVA (Enova International Inc.) holds a C- grade (61/100 RQD, P/E 14.4x, ROIC 17.1%, cap $4.26B) and NNI (Nelnet Inc.) posts a D+ grade (53/100 RQD, P/E 10.3x, ROIC 11.6%, cap $4.38B). Among the 5-stock peer group, NNI leads on earnings multiple (10.3x) while DAVE leads on capital efficiency (55.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CORZ?
▼

Per CORZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839341), Core Scientific Inc. generated $319.0M in revenue (-37.5% YoY), -$288.6M in net income, and -$450.8M in free cash flow against $2.35B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $12.36 (-1.20%)🧬 Dilution Drag (+1.92% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (25/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.7% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510025
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E
Cash (4)Whales (5)SEC (8)Macro (3)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-14.9% Base Target
$32 Bull$11 Base$8 Bear
📬 FREE CORZ RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CORZ)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (25/100 Composite)
🔍 WHY CORZ SCORES 25/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (32% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Whale & Options Positioning+5/20 pts (20% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Macro Regime Fit4/20 pts (-16 pt drag)

Macro rate sensitivity & RSI-14 (40.8) create a -16 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
33
Grade E$13.51+5.5% Next Q
Q2 (-2Q)
30
Grade E$14.25+5.3% Next Q
Q3 (-1Q)
28
Grade E$15.00-16.6% Next Q
Current
25
Grade E$12.51-10.7% Hist 90D α
Trajectory: E (33) → E (25)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CORZ Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CORZ currently carries a cautious 25/100 (E) rating due to Macro Regime Fit (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($15.97) and Max Pain ($13.14) forces dealer call-delta covering toward $31.98.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CORZ• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “CORZ Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 25%NO 75%Trade / Inspect Odds →
NEXT EST. WINDOW: Dec 30, 2026 (~56 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$1.56 Expected Swing
$10.95 (-12.5%)Spot $12.51$14.07 (+12.5%)
MODEL EARNINGS SETUP GAUGE

CORZ Quantitative Pre-Earnings Setup: 25/100

Trailing EPS: $-0.90 • YoY Revenue Growth: -37.5%

Model Bullish Setup (25/100)Model Risk Weight (75/100)
Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).
LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-12-31$319.0M-$288.6M-$450.8M11.9%
FY 20242024-12-31$510.7M-$1.44B-$52.1M23.7%
FY 20232023-12-31$502.4M-$246.5M$42.5M11.9%
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CORZ)

  • ✓Walkthrough of CORZ's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
CORZ // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -40.71%🛡️ HOLDING TREND SUPPORT
2026-11-03O $14.43H $14.43L $12.51C $12.51VOL 18.92M
RES: $15.41SUP: $10.82SMA50: $15.97SMA200: $19.59
$31.73$26.47$21.20$15.94$10.68RES $15.41SUP $10.82$12.512026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CORZ Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CORZ Butterfly Map → + Track CORZ →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
22.3%/yr Implied 5Y Growth

vs. -37.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on CORZ today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CORZ. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CORZ today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CORZ)

Financials Rank #1058 of 1097 ⚔️ ENVA vs CORZ Full Matrix →

1. Head-to-Head Financials Peer Comparison (CORZ vs. ENVA, NNI, DAVE, SEZL)

Industry: Finance: Consumer Services (156 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, Core Scientific Inc. (CORZ) ranks #1058 by composite RQD confidence (25/100, grade E) and #303 by equity capitalization ($4.26B). Within this direct 5-issuer industry benchmark cohort, NNI leads on earnings valuation at 10.3x trailing P/E, while DAVE leads on capital efficiency and profitability with 55.3% ROIC and — gross margin. SEZL currently holds the highest overall quantitative score in the immediate peer group at 79/100 (B+) compared with CORZ at 25/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
CORZ ACTIVE
Core Scientific Inc.
E 25/100 — — -35.0% -5.62% $4.26B Benchmark Subject
ENVA
Enova International Inc.
C- 61/100 14.4x — 17.1% -0.09% $4.26B /enva-vs-corz →
NNI
Nelnet Inc.
D+ 53/100 10.3x — 11.6% +1.47% $4.38B /nni-vs-corz →
DAVE
Dave Inc.
B+ 76/100 21.8x — 55.3% +1.61% $4.04B /dave-vs-corz →
SEZL
Sezzle Inc.
B+ 79/100 — — 38.6% -4.84% $4.56B /sezl-vs-corz →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001839341 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Core Scientific Inc. (CORZ) reported GAAP revenue of $319.0M (-37.5% vs. FY2024 revenue of $510.7M , and -36.5% cumulative change since FY2023) , GAAP net income of -$288.6M, operating cash flow of $278.3M, and free cash flow of -$450.8M (-765.7% YoY). On the balance sheet, CORZ closed FY2025 with $2.35B in total assets against $1.06B in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $319.0M -$288.6M $278.3M -$450.8M $2.35B $1.06B
FY2024 (FY) 2024-12-31 $510.7M -$1.44B $42.9M -$52.1M $1.48B $1.09B
FY2023 (FY) 2023-12-31 $502.4M -$246.5M $65.1M $42.5M $2.55B $596.8M

3. CORZ Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CORZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Core Scientific Inc. (NASDAQ: CORZ) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $12.51 (-5.62% 1D, market cap $4.26B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 3/20, and Executive Insider Alignment 5/20. Across 1097 tracked Financials issuers, CORZ ranks #1058 in composite RQD confidence.

How does CORZ compare to ENVA and NNI in the Financials sector?

Within the Financials sector (Finance: Consumer Services), CORZ carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, ENVA (Enova International Inc.) holds a C- grade (61/100 RQD, P/E 14.4x, ROIC 17.1%, cap $4.26B) and NNI (Nelnet Inc.) posts a D+ grade (53/100 RQD, P/E 10.3x, ROIC 11.6%, cap $4.38B). Among the 5-stock peer group, NNI leads on earnings multiple (10.3x) while DAVE leads on capital efficiency (55.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CORZ?

Per CORZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839341), Core Scientific Inc. generated $319.0M in revenue (-37.5% YoY), -$288.6M in net income, and -$450.8M in free cash flow against $2.35B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CORZ trading relative to its 50-day, 200-day, and 52-week technical levels?

CORZ last traded at $12.51 (-5.62% on volume of 12,207,818 shares), positioning the stock -21.67% below its 50-day simple moving average ($15.97) and -36.14% below its 200-day simple moving average ($19.59). Across its 52-week range of $12.31 to $30.46, CORZ sits at the 1.1% percentile with a 14-day RSI of 40.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($10.95 to $14.07).

Direct Sub-Reports: CORZ RQD Cockpit CORZ 12M Forecast CORZ Earnings & Move CORZ Dividends & DRIP CORZ Insiders & 13F CORZ Whale Options CORZ Profit Sankey CORZ News & Why
ROARABLE RATING BRIEF • RQD 25/100 (E) ✓ SEC XBRL & RQD VERIFIED

CORZ — Core Scientific Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Core Scientific Inc. (CORZ) earns a live Roarable RQD composite score of 25/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $12.51 (-5.62% 1D, market capitalization $4.26B).

  • Fundamental Cash Engine (4/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of —, operating margin of -60.0%, and free cash flow yield of -9.72%.
  • Whale 13F & Options Flow (5/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (3/20) + Forensic Balance Sheet (8/20): Incorporates a 1.12x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 5/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Core Scientific Inc. Is a NASDAQ-listed issuer classified under the Financials sector and the Finance: Consumer Services industry. The company reported FY 2025 revenue of $319.0M. The Butterfly Supply-Chain Graph lists supply chain as "NONE," so no upstream or downstream relationships are mapped.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Core Scientific Inc. (CORZ) reported $319.0M in annual revenue (up from $510.7M in FY2024, -37.5% YoY) and -$288.6M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($502.4M revenue, -$246.5M net income) through FY2025, CORZ scaled operating cash flow to $278.3M and free cash flow to -$450.8M, backed by $2.35B in total assets against $1.06B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (E • RQD 25/100): Established market leader in Financials with deep daily trading liquidity. Free cash flow yield of -9.72% and institutional whale pillar of 5/20. With Fundamental Cash Engine at 4/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $12.31 – $30.46 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.12x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

— The Butterfly Supply-Chain Graph lists supply chain as "NONE," with empty butterfly links and empty proprietary signals.

  • Key Question #1: Can CORZ sustain or expand its -60.0% operating margin and -35.0% ROIC against Finance: Consumer Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $319.0M and free cash flow of -$450.8M, how will capital allocation balance growth reinvestment against $1.06B in total debt?
  • Key Question #3: How sensitive is CORZ's 29.0x forward P/E multiple to Financials capital spending cycles and macro interest-rate shifts (Beta 1.12x)?

CORZ Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Core Scientific Inc. (CORZ) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CORZ Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CORZ Bull vs. Bear Conversation Board — What's Your Call at $12.51?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CORZ 🐻 33% BEARISH CONVICTION
1. Pick Your Side on CORZ:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MI MidwestValue RQD DEBATE OPENER • Fundamental Long-Only 🐂 BULLISH 🎯 Target: $17.09 (+29.0%)
📌 Pinned Debate

Per the news wire, a Seeking Alpha report frames the stock as a cheap buying opportunity after a meltdown and bottoming, citing AMD's a

The street is overcomplicating Core Scientific Inc. (CORZ). Per the news wire, a Seeking Alpha report frames the stock as a cheap buying opportunity after a meltdown and bottoming, citing AMD's approval.. With an RQD score of 25/100 (E) and Forensic Balance Sheet at 8/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $14.31.

SectorRotator 🐂 BULL

@SkepticalCFA Fair point on 29.0x forward P/E, but you're ignoring the forward operating leverage in Finance: Consumer Services. If gross margin (0.0%) holds, EPS grows into the multiple faster than bears think.

SK SkepticalCFA RQD DEBATE OPENER • Fundamental Contrarian 🐻 BEARISH 🎯 Target: $10.73 (-19.0%)
Spot @ $13.25

Per the RQD rating, ROIC of -35% and FCF yield of -9.72% leave the Fundamental Cash Engine pillar at 4 of 20.

I respect the product at Core Scientific Inc., but the stock at $13.25 is a different story. Per the RQD rating, ROIC of -35% and FCF yield of -9.72% leave the Fundamental Cash Engine pillar at 4 of 20.. FCF yield is -9.72% and RQD sits at 25/100 (E) — why pay up here when you can wait for next quarter's numbers?

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%